Literature DB >> 8664280

Dimerization of the extracellular domain of granuloycte-colony stimulating factor receptor by ligand binding: a monovalent ligand induces 2:2 complexes.

T Horan1, J Wen, L Narhi, V Parker, A Garcia, T Arakawa, J Philo.   

Abstract

Granulocyte-colony stimulating factor (G-CSF) binds to a specific cell surface receptor and induces signals for growth and differentiation in cells of granulocyte hematopoietic lineage. In order to understand how G-CSF binding initiates signals into these cells, we have studied its interactions with the entire extracellular domain of the receptor (sG-CSFR). The sG-CSFR was purified from CHO cell conditioned media with a G-CSF affinity column, resting in a preparation fully competent for ligand binding. However, when sG-CSFR was purified by conventional means, i.e., without affinity chromatography, only about half was competent. Therefore, all studies were carried out using affinity-purified material. The sG-CSFR exhibited a weak self-association into a dimer with a dissociation constant of 200microM in the absence of G-CSF. Addition of G-CSF dimerizes the receptor, with a preferred stoichiometry of 2 G-CSF molecules plus 2 receptors. Unexpectedly, receptor-receptor interactions rather than through two receptors binding to the same G-CSF molecule; i.e., G-CSF is a monovalent ligand. G-CSF binding to the receptor monomer occurs with high affinity. The binding of G-CSF also enhances the receptor-receptor dimerization; when G-CSF is bound to both receptors, dimerization is enhanced 2000-fold, while the interaction of a 1:1 receptor-ligand complex with a second ligand-free receptor is enhanced 80-fold. Thus, the mechanism of receptor dimerization is fundamentally different than that of related cytokine receptors such as growth hormone and erythropoietin receptors. Circular dichroic spectra showed a small but significant conformational change of receptor upon binding G-CSF. This is consistent with the idea that G-CSF binding alters the conformation of the receptor, resulting in an increase in receptor-receptor interactions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8664280     DOI: 10.1021/bi9525841

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition.

Authors:  H M Mehta; M Futami; T Glaubach; D W Lee; J R Andolina; Q Yang; Z Whichard; M Quinn; H F Lu; W M Kao; B Przychodzen; C A Sarkar; A Minella; J P Maciejewski; S J Corey
Journal:  Leukemia       Date:  2013-10-30       Impact factor: 11.528

2.  An insight into the thermodynamic characteristics of human thrombopoietin complexation with TN1 antibody.

Authors:  Shigeki Arai; Chie Shibazaki; Motoyasu Adachi; Eijiro Honjo; Taro Tamada; Yoshitake Maeda; Tomoyuki Tahara; Takashi Kato; Hiroshi Miyazaki; Michael Blaber; Ryota Kuroki
Journal:  Protein Sci       Date:  2016-07-25       Impact factor: 6.725

3.  Characterization of the receptor binding determinants of granulocyte colony stimulating factor.

Authors:  D C Young; H Zhan; Q L Cheng; J Hou; D J Matthews
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

4.  Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.

Authors:  H Kim; H Baumann
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

5.  Two EGF molecules contribute additively to stabilization of the EGFR dimer.

Authors:  M A Lemmon; Z Bu; J E Ladbury; M Zhou; D Pinchasi; I Lax; D M Engelman; J Schlessinger
Journal:  EMBO J       Date:  1997-01-15       Impact factor: 11.598

6.  Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors.

Authors:  A Hammacher; J Wijdenes; D J Hilton; N A Nicola; R J Simpson; J E Layton
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

7.  Development of a cytokine analog with enhanced stability using computational ultrahigh throughput screening.

Authors:  Peizhi Luo; Robert J Hayes; Cheryl Chan; Diane M Stark; Marian Y Hwang; Jonathan M Jacinto; Padmaja Juvvadi; Helen S Chung; Anirban Kundu; Marie L Ary; Bassil I Dahiyat
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

Review 8.  G-CSF and GM-CSF in Neutropenia.

Authors:  Hrishikesh M Mehta; Michael Malandra; Seth J Corey
Journal:  J Immunol       Date:  2015-08-15       Impact factor: 5.422

9.  Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex.

Authors:  Taro Tamada; Eijiro Honjo; Yoshitake Maeda; Tomoyuki Okamoto; Matsujiro Ishibashi; Masao Tokunaga; Ryota Kuroki
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

10.  Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment.

Authors:  A C Ward; Y M van Aesch; J Gits; A M Schelen; J P de Koning; D van Leeuwen; M H Freedman; I P Touw
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.